Characteristics | COPD P.A. group | Control group | P |
---|---|---|---|
No. | 20 | 10 | Â |
Age, year | 67.15 ± 8.99 | 63.7 ± 5.69 | 0.280 |
BMI, kg/m2 | 22.39 ± 3.33 | 24.04 ± 1.44 | 0.147 |
Smoking | |||
Current smoker | 100% (20) | 50% (5) | < 0.001 |
Pack-years | 32.50 (25.00, 50.00) | 15 (0.00, 36.25) | 0.039 |
Lung Function | |||
FEV1, L | 1.48 ± 0.44 | 2.64 ± 0.75 | < 0.001 |
FVC, L | 3.03 ± 0.63 | 3.52 ± 1.14 | 0.233 |
 FEV1/FVC | 0.49 ± 0.09 | 0.76 ± 0.05 | < 0.001 |
GOLD-stage | |||
 I | 5% (1) | / | / |
 II | 65% (13) | / | / |
 III | 30% (6) | / | / |
 IV | 0% (0) | / | / |
Inflammatory markers | |||
WBC,109/L | 9.84 ± 0.93 | 6.29 ± 0.99 | < 0.001 |
NEU,109/L | 7.12 ± 1.12 | 3.20 ± 0.66 | < 0.001 |
LYM,109/L | 1.79 ± 0.51 | 2.27 ± 0.43 | 0.015 |
MONO,109/L | 0.49 ± 0.09 | 0.41 ± 0.15 | 0.074 |
EOS,109/L | 0.28 ± 0.22 | 0.19 ± 0.06 | 0.204 |